Notably, SHP2 is required for full activation of the RAS/MAPK signaling cascade, and dominantly acting mutations of PTPN11, the gene encoding SHP2, cause developmental disorders (i.e., Noonan syndrome4–7 and Noonan syndrome with multiple lentigines6,8). Here, PTPN11 is linked to Noonan syndrome.